Heart attack patients without traditional risk factors have high levels of coronary calcium, study finds

While high cholesterol, high blood pressure, diabetes and smoking are well known heart disease risks, not everyone who has a heart attack has them.

Toripalimab by Shanghai Junshi Biosciences for Urethral Cancer: Likelihood of Approval – Pharmaceutical Technology

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 19, 2023

Coronary artery calcium scoring with CT can predict risk of heart attacks or strokes

Coronary artery calcium scoring with CT can identify symptomatic patients with a very low risk of heart attacks or strokes, according to a new study

March 5, 2024

Senseonics tips 365-day CGM to double 2025 sales

Dive Brief: Senseonics expects the launch of its 365-day continuous glucose monitor (CGM) implant to help double its user base and sales in 2025, the

June 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.